TCL Archive Advisors Approve New Grant Programs In Breast Pre-Malignancy, Lung Inflammation November 17, 2006
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive IOM Committee Focuses on Studies Needed To Protect Patients On Omics-Based Trials November 4, 2011
